CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 5,000 enrolled
Drug / intervention
Angiography derived index of micro-circulatory resistance (Angio-IMR)other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05696379
NCT05696379N/ACompleted

Angiography Derived Index of Microcirculatory Resistance in Patients With Acute Myocardial Infarction

Second Affiliated Hospital, School of Medicine, Zhejiang University·observational·Posted Jan 25, 2023·Updated Jan 25, 2023

In Brief

An observational study evaluating Angiography derived index of micro-circulatory resistance (Angio-IMR) for Acute Myocardial Infarction (AMI). Completed, enrolled 5,000 participants across 1 site.

Detailed Summary

Coronary microcirculatory dysfunction has been known to be prevalent even after successful revascularization of acute myocardial infarction (AMI) patients, and has been shown to be associated with poor prognosis. Angiography derived index of micro-circulatory resistance (Angio-IMR) is a novel pressure-wire free approach to assess coronary microvascular disease with great diagnostic performance. The current study will further investigate the prognostic value of Angio-IMR in patients with AMI in multicenter retrospective cohort.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesChina

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJan 25, 2023
Enrollment StartJun 1, 2017
Primary CompletionMay 31, 2022
TodayJul 2, 2026
Enrollment to primary: 5 yearsPosted 3.4 years ago

Interventions

Angiography derived index of micro-circulatory resistance (Angio-IMR)other

Angiography derived index of micro-circulatory resistance (Angio-IMR) post percutaneous coronary intervention.